Skip to main content
. 2018 Mar 9;58(3):1125–1136. doi: 10.1007/s00394-018-1630-4

Table 3.

Multivariable HRs with 95% CIs for the associations between the intakes of individual SFA (en %) and incidence of type 2 diabetes in 37,421 participants from the EPIC-NL cohort

Median intake (en%/day) SDa Model 1b Model 2c Model 3d Model 4e Model 5f
Lauric acid (12:0) 0.63 0.24 1.03 (0.97, 1.10) 0.88 (0.82, 0.94) 0.89 (0.83, 0.95) 0.89 (0.83, 0.97) 0.92 (0.85, 0.99)
Myristic acid (14:0) 1.51 0.45 1.04 (0.97, 1.10) 0.89 (0.83, 0.96) 0.91 (0.85, 0.97) 0.78 (0.70, 0.87) 0.89 (0.79, 0.99)
Pentadecylic (15:0) 0.21 0.08 1.01 (0.94, 1.08) 0.89 (0.82, 0.95) 0.92 (0.86, 0.99) 0.79 (0.71, 0.88) 0.90 (0.80, 1.00)
Palmitic acid (16:0) 7.06 1.22 1.08 (1.02, 1.16) 1.05 (0.99, 1.12) 1.05 (0.98, 1.11) 0.95 (0.84, 1.08) 0.90 (0.80, 1.03)
Margaric acid (17:0) 0.16 0.04 1.09 (1.02, 1.17) 1.00 (0.93, 1.07) 1.02 (0.95, 1.09) 0.76 (0.66, 0.87) 0.84 (0.73, 0.97)
Stearic acid (18:0) 3.47 0.68 1.09 (1.02, 1.16) 1.06 (0.99, 1.13) 1.04 (0.98, 1.11) 1.01 (0.90, 1.12) 0.92 (0.83, 1.03)
Sum of butyric (4:0) to capric (10:0) acids 0.67 0.28 1.00 (0.94, 1.07) 0.87 (0.81, 0.94) 0.91 (0.85, 0.98) 0.86 (0.79, 0.94) 0.93 (0.85, 1.01)
Sum of pentadecylic (15:0) and margaric(17:0) acids 0.37 0.11 1.04 (0.97, 1.10) 0.93 (0.87, 0.99) 0.96 (0.89, 1.02) 0.78 (0.69, 0.87) 0.88 (0.79, 0.99)

Obtained from Cox proportional hazards regression models. EPIC-NL, European Prospective Investigation into Cancer and Nutrition-Netherlands

aHRs are expressed per SD en%

bCrude model; adjusted for total energy intake

cAdjusted for sex, age and sum of other SFA

dAdditional adjustments for education level, energy-adjusted alcohol consumption level, smoking status, physical activity level

eAdditional adjustments for energy-adjusted intake of animal protein, vegetable protein, trans fatty acids, vitamin E, dietary fibre and cholesterol

fAdditional adjustments for BMI and waist circumference